News | November 10, 2023
Intermountain Health files complain against Dr. Reddy’s and others
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Fluocinolone Acetonide Oil (RLD Derma-Smoothe/FS®) had estimated annual sales of USD 10 million in the U.S. (IQVIA MAT June 2023)
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Mindset disagrees with and denies the allegations set forth from Reunion.
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Subscribe To Our Newsletter & Stay Updated
